Peter Klare Selected Research

Gemcitabine

7/2008

Nonplatinum topotecan combinations versus topotecan alone for recurrent ovarian cancer: results of a phase III study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Klare Research Topics

Disease

15	Breast Neoplasms (Breast Cancer) 01/2023 - 08/2007
7	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 02/2008
5	Neoplasms (Cancer) 01/2023 - 07/2008
5	Triple Negative Breast Neoplasms 01/2022 - 06/2014
3	Neoplasm Metastasis (Metastasis) 01/2023 - 10/2019
3	Adenoma (Adenomas) 01/2020 - 02/2015
3	Carcinoma (Carcinomatosis) 10/2017 - 08/2012
3	Thrombocytopenia (Thrombopenia) 01/2017 - 08/2008
3	Neutropenia 01/2015 - 08/2008
2	Polyps 03/2019 - 01/2018
2	Hypoxia (Hypoxemia) 01/2016 - 12/2015
2	Nausea 11/2015 - 08/2008
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Leukopenia 01/2017
1	Abdominal Pain (Pain, Abdominal) 01/2017
1	Ascites 01/2017
1	Apnea 01/2016
1	Hypotension (Low Blood Pressure) 12/2015
1	Pathologic Complete Response 03/2015
1	Febrile Neutropenia 01/2015
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2015
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2015
1	Vomiting 08/2008
1	Alopecia (Baldness) 08/2008
1	Ovarian Epithelial Carcinoma 03/2008
1	Body Weight (Weight, Body) 08/2007

Drug/Important Bio-Agent (IBA)

8	taxaneIBA 01/2023 - 08/2007
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 02/2008
7	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 02/2008
6	AnthracyclinesIBA 01/2023 - 08/2007
4	Trastuzumab (Herceptin)FDA Link 12/2022 - 08/2007
4	PlatinumIBA 06/2014 - 03/2008
3	Bevacizumab (Avastin)FDA Link 01/2023 - 06/2014
3	liposomal doxorubicin (Doxil)FDA Link 01/2022 - 03/2008
3	Propofol (Diprivan)FDA LinkGeneric 01/2020 - 12/2015
3	human ERBB2 proteinIBA 10/2017 - 08/2007
3	treosulfanIBA 01/2017 - 08/2012
2	Hormones (Hormone)IBA 11/2022 - 10/2021
2	Epirubicin (Ellence)FDA LinkGeneric 01/2022 - 01/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 10/2021 - 03/2015
2	Capecitabine (Xeloda)FDA Link 04/2020 - 08/2007
2	Phenobarbital (Luminal)FDA Link 10/2019 - 10/2017
2	Alkylating AgentsIBA 12/2015 - 08/2012
2	Topotecan (Hycamtin)FDA LinkGeneric 08/2008 - 07/2008
1	pertuzumabIBA 11/2022
1	exemestane (Aromasin)FDA Link 04/2020
1	Everolimus FDA Link 04/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Acetic Acid (Vinegar)FDA LinkGeneric 03/2019
1	SolutionsIBA 03/2019
1	Coloring Agents (Dyes)IBA 01/2018
1	cabazitaxel FDA Link 10/2017
1	ParaffinIBA 10/2016
1	Formaldehyde (Formol)FDA Link 10/2016
1	Midazolam (Versed)FDA LinkGeneric 01/2016
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 11/2015
1	Messenger RNA (mRNA)IBA 03/2015
1	Indicators and Reagents (Reagents)IBA 02/2015
1	pegfilgrastim (Neulasta)FDA Link 01/2015
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2015
1	SaltsIBA 06/2014
1	Etoposide (VP 16)FDA LinkGeneric 07/2008
1	Gemcitabine FDA Link 07/2008
1	Cytotoxins (Cytolysins)IBA 03/2008
1	1-dodecylpyridoxal (PLD)IBA 03/2008
1	dimemorfan (AT 17)IBA 02/2008
1	Monoclonal AntibodiesIBA 08/2007
1	Taxoids (Taxanes)IBA 08/2007
1	CarbamatesIBA 08/2007

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2023 - 07/2008
9	Neoadjuvant Therapy 01/2022 - 06/2014
6	Therapeutics 01/2023 - 03/2008
1	Subcutaneous Injections 12/2022
1	Surgical Instruments (Clip) 01/2015
1	Treatment Delay 08/2008